Targa Resources Corp.:企業の戦略・SWOT・財務情報

◆英語タイトル:Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1111
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:環境
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Targa Resources Corp. – Strategy, SWOT and Corporate Finance Report
Summary

Targa Resources Corp. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Targa Resources Corp. (Targa or ‘the company’) a midstream energy company involved in the business of gathering, compressing, treating, processing, and selling natural gas. The company is also involved in storing, fractionating, treating, transporting, terminaling and selling natural gas liquids (NGLs) and NGL products, refined petroleum products and crude oil. The company distributes and markets its products directly to the NGL customers and through trucks, barges, ships, rail cars and open-access regulated NGL pipelines owned by third parties. It operates its terminal facilities in a number of states including Texas, Oklahoma, Louisiana, Arizona, Nevada, California, Florida, Alabama, Mississippi, Tennessee, Kentucky, New Jersey and Washington. Targa is headquartered in Houston, Texas, the US.

Scope

- Detailed information on Targa Resources Corp. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Targa Resources Corp. in the form of a SWOT analysis
- An in-depth view of the business model of Targa Resources Corp. including a breakdown and examination of key business segments
- Intelligence on Targa Resources Corp.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Targa Resources Corp., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Targa Resources Corp. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Targa Resources Corp. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Targa Resources Corp.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Targa Resources Corp.: Company Overview 9
Targa Resources Corp.: Overview and Key Facts 9
Targa Resources Corp.: Overview 9
Targa Resources Corp.: Key Facts 9
Targa Resources Corp.: Key Employees 11
Targa Resources Corp.: Key Employee Biographies 13
Targa Resources Corp.: Major Products and Services 17
Targa Resources Corp.: Company History 18
Targa Resources Corp.: Management Statement 21
Targa Resources Corp.: Locations and Subsidiaries 29
Targa Resources Corp.: Key Competitors 30
Targa Resources Corp.: Company Analysis 31
Targa Resources Corp.: Business Description 31
Targa Resources Corp.: SWOT Analysis 33
Targa Resources Corp.: SWOT Overview 33
Targa Resources Corp.: Strengths 33
Targa Resources Corp.: Weaknesses 34
Targa Resources Corp.: Opportunities 34
Targa Resources Corp.: Threats 35
Targa Resources Corp.: Corporate Financial Deals Activity 37
Targa Resources Corp.: Financial Deals Overview 37
Targa Resources Corp.: Targets and Partners 39
Targa Resources Corp.: Top Deals 2014 – 2018YTD* 40
Targa Resources Corp.: Advisors 42
Targa Resources Corp.: Top Legal Advisors 42
Targa Resources Corp.: Top Financial Advisors 42
Targa Resources Corp.: Mergers and Acquisitions 43
Targa Resources Corp.: Capital Raising 44
Targa Resources Corp.: Partnership 45
Targa Resources Corp.: Divestments 46
Targa Resources Corp.: Private Equity and Ownership 47
Targa Resources Corp.: Recent Developments 48
Targa Resources Corp.: News and Events Summary 48
Targa Resources Corp.: Business Expansion 51
Targa Resources Corp.: Contracts 52
Targa Resources Corp.: Corporate Governance 53
Targa Resources Corp.: Financial Performance 53
Targa Resources Corp.: Regulatory and Legal Events 53
Targa Resources Corp.: Strategy and Operations 54
Appendix 57
Contact Us 57
Methodology 57
About MarketLine 58

List of Tables
Table 1: Targa Resources Corp.: Key Facts
Table 2: Targa Resources Corp.: Key Employees
Table 3: Targa Resources Corp.: Locations and Subsidiaries
Table 4: Targa Resources Corp.: Key Competitors
Table 5: Targa Resources Corp.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Targa Resources Corp.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Targa Resources Corp.: M&A Average Deal Size - Value (US$m)
Table 8: Targa Resources Corp.: Targets and Partners
Table 9: Targa Resources Corp.: Top Deals 2014 - 2018YTD*
Table 10: Targa Resources Corp.: Legal Advisor Ranking by Value (US$m)
Table 11: Targa Resources Corp.: Financial Advisor Ranking by Value (US$m)
Table 12: Targa Resources Corp.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Targa Resources Corp.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Targa Resources Corp.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Targa Resources Corp.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Targa Resources Corp.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Targa Resources Corp.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Targa Resources Corp.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Targa Resources Corp.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Targa Resources Corp.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Targa Resources Corp.: News and Events Summary
Table 22: Targa Resources Corp.: Business Expansion
Table 23: Targa Resources Corp.: Contracts
Table 24: Targa Resources Corp.: Corporate Governance
Table 25: Targa Resources Corp.: Financial Performance
Table 26: Targa Resources Corp.: Regulatory and Legal Events
Table 27: Targa Resources Corp.: Strategy and Operations

List of Figures
Figure 1: Targa Resources Corp.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Targa Resources Corp.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Targa Resources Corp.: M&A Average Deal Size - Value (US$m)
Figure 4: Targa Resources Corp.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Targa Resources Corp.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Targa Resources Corp.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Targa Resources Corp.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Targa Resources Corp.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Targa Resources Corp.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Targa Resources Corp.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Targa Resources Corp.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Targa Resources Corp.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Targa Resources Corp.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TiGenix NV (TIG):医療機器:M&Aディール及び事業提携情報
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Medical Research Council-製薬・医療分野:企業M&A・提携分析
    Summary Medical Research Council (MRC) is a human health research council that offers medical research programs. The council offers research across medical sciences services, universities and hospitals, centers and institutes. It provides data management, research platform, tools and facilities to g …
  • Edcon Holdings (Proprietary) Limited:戦略・SWOT・企業財務分析
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Alstom SA (ALO):電力:M&Aディール及び事業提携情報
    Summary Alstom SA (Alstom) is a marketer and developer of transport systems. The company offers a wide range of solutions ranging from high-speed trains to metros and tramways including customized services such as maintenance and modernization, and infrastructure up to signaling solutions. It design …
  • Carmanah Technologies Corporation:企業の戦略的SWOT分析
    Carmanah Technologies Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Datwyler Holding Inc (DAE):企業の財務・戦略的SWOT分析
    Datwyler Holding Inc (DAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Egmont International Holding AS:企業の戦略的SWOT分析
    Egmont International Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Unilever Plc (ULVR):企業の財務・戦略的SWOT分析
    Unilever Plc (ULVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Human Longevity Inc-製薬・医療分野:企業M&A・提携分析
    Summary Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data. Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomark …
  • Neste Corporation (NESTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Neste Corp (Neste) is an oil refining and marketing company that offers advanced, clean traffic fuels besides shipping and engineering services. The company produces and sells gasoline; diesel fuel; aviation fuel; bunker fuel; heating oil; light and heavy fuel oil; base oils; gasoline compon …
  • Caldera Health Ltd:製品パイプライン分析
    Summary Caldera Health Ltd (Caldera) is a medical device company that develops prostate cancer diagnostic tools. The company develops prostate cancer diagnostic tools to detect and monitor the cancer disease. It also develops proscanZ and auditor tests based on the enzyme linked immunoassays or ELIS …
  • Cerus Corp (CERS):製薬・医療:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Genfit SA (GNFT):医療機器:M&Aディール及び事業提携情報
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • Osaka Gas Co Ltd (9532):石油・ガス:M&Aディール及び事業提携情報
    Summary Osaka Gas Co Ltd (OGCL) supplies natural gas to its customers in Kansai region, besides offering LPG, electricity and other energy-related products and services through affiliated enterprises. Its operations consist of domestic energy, environmental and non-energy, and international energy b …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • DPL Inc:企業の戦略的SWOT分析
    DPL Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Regis Healthcare Ltd:企業の戦略・SWOT・財務情報
    Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tencent Holdings Limited:企業のM&A・事業提携・投資動向
    Tencent Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tencent Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • PharmAust Ltd (PAA)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAust Ltd (PharmAust) is a drug discovery and development company which provides human and veterinary proprietary medicines to treat different types of cancers. The company provides specialized medicinal and synthetic chemistry services. It specializes in bio defense and laboratory suppo …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona) formerly Aniona, is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆